纳曲酮的新型 3-O-聚乙二醇羧酸酯和 3-O-聚乙二醇碳酸酯前药用于微针增强经皮给药。
Novel 3-O-pegylated carboxylate and 3-O-pegylated carbamate prodrugs of naltrexone for microneedle-enhanced transdermal delivery.
机构信息
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536, USA.
出版信息
Bioorg Med Chem Lett. 2010 Jun 1;20(11):3280-3. doi: 10.1016/j.bmcl.2010.04.049. Epub 2010 Apr 18.
Abstract
A small library of novel 3-O-pegylated carboxylate prodrugs (4a-4b) and 3-O-pegylated carbamate prodrugs (9a-9b) of naltrexone were synthesized. The goal behind the design of these prodrugs was to investigate their potential for microneedle-enhanced transdermal delivery. All the synthesized 3-O-pegylated carboxylate prodrugs (4a-4b) and 3-O-pegylated carbamate prodrugs (9a-9b) of naltrexone were found to have adequate stability in a transdermal formulation and improved apparent solubility compared to naltrexone. Viscosity effects were postulated to be responsible for the observed non-linearity in the flux-concentration profile of these prodrugs.
摘要
我们合成了一系列新型的纳曲酮 3-O-聚乙二醇羧酸酯前药（4a-4b）和 3-O-聚乙二醇氨基甲酸酯前药（9a-9b）。设计这些前药的目的是研究它们经微针增强透皮给药的潜力。所有合成的纳曲酮 3-O-聚乙二醇羧酸酯前药（4a-4b）和 3-O-聚乙二醇氨基甲酸酯前药（9a-9b）在透皮制剂中都表现出足够的稳定性，与纳曲酮相比，表观溶解度也有所提高。我们推测，黏度效应是这些前药的通量-浓度曲线呈现非线性的原因。
相似文献
1
Novel 3-O-pegylated carboxylate and 3-O-pegylated carbamate prodrugs of naltrexone for microneedle-enhanced transdermal delivery.纳曲酮的新型 3-O-聚乙二醇羧酸酯和 3-O-聚乙二醇碳酸酯前药用于微针增强经皮给药。
Bioorg Med Chem Lett. 2010 Jun 1;20(11):3280-3. doi: 10.1016/j.bmcl.2010.04.049. Epub 2010 Apr 18.
2
In vitro permeation of a pegylated naltrexone prodrug across microneedle-treated skin.经微针处理的皮肤中聚乙二醇化纳曲酮前药的体外渗透。
J Control Release. 2010 Aug 17;146(1):37-44. doi: 10.1016/j.jconrel.2010.05.034. Epub 2010 Jun 4.
3
Vehicle composition influence on the microneedle-enhanced transdermal flux of naltrexone hydrochloride.车辆组成对盐酸纳曲酮经皮微针增强通量的影响。
Pharm Res. 2011 Jan;28(1):124-34. doi: 10.1007/s11095-010-0191-x. Epub 2010 Jun 25.
4
In vitro/in vivo correlation of transdermal naltrexone prodrugs in hairless guinea pigs.无毛豚鼠中透皮纳曲酮前药的体外/体内相关性
Pharm Res. 2005 Jun;22(6):981-9. doi: 10.1007/s11095-005-4593-0. Epub 2005 Jun 8.
5
In vitro release studies on matrix type transdermal drug delivery systems of naltrexone and its acetyl prodrug.
Drug Dev Ind Pharm. 2005 Oct;31(9):871-7. doi: 10.1080/03639040500271944.
6
Synthesis and in vitro stability of amino acid prodrugs of 6-β-naltrexol for microneedle-enhanced transdermal delivery.用于微针增强透皮给药的6-β-纳曲醇氨基酸前药的合成及其体外稳定性
Bioorg Med Chem Lett. 2014 Nov 15;24(22):5212-5. doi: 10.1016/j.bmcl.2014.09.072. Epub 2014 Oct 2.
7
Naltrexone salt selection for enhanced transdermal permeation through microneedle-treated skin.纳曲酮盐的选择用于增强经微针处理后的皮肤的透皮渗透。
J Pharm Sci. 2012 Aug;101(8):2777-86. doi: 10.1002/jps.23189. Epub 2012 May 24.
8
A duplex "Gemini" prodrug of naltrexone for transdermal delivery.一种用于透皮给药的纳曲酮双功能“双子星”前药。
J Control Release. 2004 Jun 18;97(2):283-90. doi: 10.1016/j.jconrel.2004.03.020.
9
Optimization of naltrexone diclofenac codrugs for sustained drug delivery across microneedle-treated skin.优化纳曲酮双氯芬酸共前药经微针处理皮肤的持续药物递送。
Pharm Res. 2014 Jan;31(1):148-59. doi: 10.1007/s11095-013-1147-8. Epub 2013 Aug 14.
10
Development of a codrug approach for sustained drug delivery across microneedle-treated skin.开发一种前药方法，以实现经微针处理的皮肤的药物持续释放。
J Pharm Sci. 2013 May;102(5):1458-67. doi: 10.1002/jps.23469. Epub 2013 Feb 15.
引用本文的文献
1
Enhancement strategies for transdermal drug delivery systems: current trends and applications.透皮给药系统的增强策略：当前趋势与应用
Drug Deliv Transl Res. 2022 Apr;12(4):758-791. doi: 10.1007/s13346-021-00909-6. Epub 2021 Jan 20.
2
Microneedles for drug and vaccine delivery.微针用于药物和疫苗传递。
Adv Drug Deliv Rev. 2012 Nov;64(14):1547-68. doi: 10.1016/j.addr.2012.04.005. Epub 2012 May 1.
3
In vitro permeation of a pegylated naltrexone prodrug across microneedle-treated skin.经微针处理的皮肤中聚乙二醇化纳曲酮前药的体外渗透。
J Control Release. 2010 Aug 17;146(1):37-44. doi: 10.1016/j.jconrel.2010.05.034. Epub 2010 Jun 4.
本文引用的文献
1
Transdermal delivery of naltrexol and skin permeability lifetime after microneedle treatment in hairless guinea pigs.经皮给予纳曲酮和无毛豚鼠经微针处理后的皮肤渗透半衰期。
J Pharm Sci. 2010 Jul;99(7):3072-80. doi: 10.1002/jps.22083.
2
Soft alkyl ether prodrugs of a model phenolic drug: the effect of incorporation of ethyleneoxy groups on transdermal delivery.模型酚类药物的软烷基醚前药：引入乙撑氧基团对透皮给药的影响。
Molecules. 2009 Oct 22;14(10):4231-45. doi: 10.3390/molecules14104231.
3
Synthesis of methoxypoly(ethylene glycol) carbonate prodrugs of zidovudine and penetration through human skin in vitro.齐多夫定甲氧基聚（乙二醇）碳酸酯前药的合成及其体外经人皮肤的渗透
J Pharm Pharmacol. 2009 Jun;61(6):721-31. doi: 10.1211/jpp.61.06.0004.
4
Microporation applications for enhancing drug delivery.用于增强药物递送的微穿孔应用。
Expert Opin Drug Deliv. 2009 Apr;6(4):343-54. doi: 10.1517/17425240902841935.
5
Transdermal drug delivery.经皮给药
Nat Biotechnol. 2008 Nov;26(11):1261-8. doi: 10.1038/nbt.1504.
6
Flux across [corrected] microneedle-treated skin is increased by increasing charge of naltrexone and naltrexol in vitro.在体外，通过增加纳曲酮和纳曲醇的电荷，经微针处理皮肤的通量会增加。
Pharm Res. 2008 Jul;25(7):1677-85. doi: 10.1007/s11095-008-9578-3. Epub 2008 May 1.
7
Influence of the delivery systems using a microneedle array on the permeation of a hydrophilic molecule, calcein.使用微针阵列的给药系统对亲水性分子钙黄绿素渗透的影响。
Eur J Pharm Biopharm. 2008 Aug;69(3):1040-5. doi: 10.1016/j.ejpb.2008.02.009. Epub 2008 Feb 19.
8
Microneedles permit transdermal delivery of a skin-impermeant medication to humans.微针可实现将皮肤渗透屏障药物经皮递送至人体。
Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2058-63. doi: 10.1073/pnas.0710355105. Epub 2008 Feb 4.
9
Characterization of solid maltose microneedles and their use for transdermal delivery.固体麦芽糖微针的表征及其经皮给药应用
Pharm Res. 2008 Jan;25(1):104-13. doi: 10.1007/s11095-007-9350-0. Epub 2007 Jun 28.
10
Development of nitrendipine transdermal patches: in vitro and ex vivo characterization.尼群地平透皮贴剂的研制：体外和离体表征
Curr Drug Deliv. 2007 Jan;4(1):69-76. doi: 10.2174/156720107779314767.
Zotero 插件